SCOPUS 정보 검색 플랫폼

Critical Reviews in Oncology/Hematology

Volumn 44, Issue 1, 2002, Pages 103-108

Biochemotherapy for advanced melanoma

(1) Buzaid, Antonio C a

a HOSPITAL SÍRIO LIBANÊS (Brazil)

Author keywords

Antitumor; Biochemotherapy; Melanoma

Indexed keywords

ALPHA INTERFERON; CARMUSTINE; CISPLATIN; DACARBAZINE; FOTEMUSTINE; INTERLEUKIN 2; LOMUSTINE; TAMOXIFEN; TEMOZOLOMIDE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CATHETER INFECTION; CHILL; CLINICAL TRIAL; DRUG RESPONSE; EDEMA; FEVER; HUMAN; MELANOMA; META ANALYSIS; METASTASIS; NAUSEA AND VOMITING; NEUROPATHY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RASH; REMISSION; IMMUNOTHERAPY; MORTALITY; MULTIMODALITY CANCER THERAPY; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; HUMANS; IMMUNOTHERAPY; MELANOMA; META-ANALYSIS; TREATMENT OUTCOME;

EID: 0036794923 PISSN: 10408428 EISSN: None Source Type: Journal
DOI: 10.1016/S1040-8428(01)00223-2 Document Type: Review

Times cited : (13)

References (31)

1
- 0033959520
- Cancer statistics 2000
- (2000) CA Cancer J. Clin. , vol.50 , pp. 7-33
- Greenlee, R.¹ Murray, T.² Bolden, S.³ Wingo, P.⁴

2
- 0001995951
- Systemic chemotherapy and biochemotherapy
- Balch C., Houghton A., Sober A., SJ S. (Eds.), Cutaneous Melanoma, St Louis: Quality Medical Publishing, Inc
- (1998) , pp. 405-418
- Buzaid, A.¹ Bedikian, A.² Houghton, A.³

3
- 0034072860
- Strategies for combining chemotherapy and biotherapy in melanoma
- (2000) Cancer Control. , vol.7 , pp. 185-197
- Buzaid, A.¹

4
- 0010886650
- Chapman P, Einhorn L, Meyers M, et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999, in press.

5
- 0000022334
- Cisplatin, vinblastine, and dacarbazine versus dacarbazine alone in metastatic melanoma: preliminary results of a phase III Cancer Community Oncology Program (CCOP) trial
- (1993) Proc. Am. Soc. Clin. Oncol. , vol.12 , pp. 389
- Buzaid, A.¹ Legha, S.² Winn, R.³

6
- 0033024863
- High-dose recombinant interleukin-2 therapy for patients with metastatic melanoma: analysis of 270 patients treated from 1985 to 1993
- (1999) J. Clin. Oncol. , vol.17 , pp. 2105-2116
- Atkins, M.¹ Lotze, M.² Dutcher, J.³

7
- 0028266553
- Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin-2
- (1994) J. Am. Med. Assoc. , vol.271 , pp. 907-913
- Rosenberg, S.¹ Yang, J.² Topalian, S.³

8
- 0002305329
- IL-2 clinical applications: melanoma
- Rosenberg S. (Ed.), Biologic Therapy of Cancer: Principles and Practice, Philadelphia: JB Lippincott Company
- (2000) , pp. 50-73
- Atkins, M.¹ Shet, A.² Sosman, J.³

9
- 0027524697
- Randomized phase III trial of treatment with high-dose interleukin-2 alone or in combination with interferon alfa-2a in patients with advanced melanoma
- (1993) J. Clin. Oncol. , vol.11 , pp. 1969-1977
- Sparano, J.¹ Fisher, R.² Sunderland, M.³

10
- 0033044110
- Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of metastatic melanoma
- (1999) J. Clin. Oncol. , vol.17 , pp. 651-657
- Richards, J.¹ Gale, D.² Mehta, N.³ Lestingi, T.⁴

11
- 18544395504
- Salpêtrière Hospital Experience with biochemotherapy in metastatic melanoma
- (1997) Cancer J. Sci. Am. , vol.3
- Antoine, E.¹ Benhammouda, A.² Bernard, A.³

12
- 0029906912
- Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-a
- (1996) Ann. Oncol. , vol.7 , pp. 827-835
- Legha, S.¹ Ring, S.² Bedikian, A.³

13
- 0031805726
- Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon-alfa, and interleukin-2 for patients with metastatic melanoma
- (1998) J. Clin. Oncol. , vol.16 , pp. 1752-1759
- Legha, S.¹ Ring, S.² Eton, O.³

14
- 0032850026
- Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma
- (1999) J. Clin. Oncol. , vol.17 , pp. 2752-2761
- O'Day, S.¹ Gammon, G.² Boasberg, P.³

15
- 0034064250
- A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma
- (2000) Mel. Res. , vol.10 , pp. 170-171
- Gibbs, P.¹ Iannucci, A.² Becker, M.³

16
- 0034043168
- A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon a-2b in patients with metastatic melanoma
- (2000) Clin. Cancer Res. , vol.6 , pp. 2202-2208
- McDermott, D.¹ Mier, J.² Lawrence, D.³

17
- 0028234182
- A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-alpha 2a in patients with advanced malignant melanoma
- (1994) Cancer Immunol. Immunother. , vol.38 , pp. 379-384
- Ron, I.¹ Mordish, Y.² Eisenthal, A.³ Skornick, Y.⁴ Inbar, M.⁵ Chaitchik, S.⁶

18
- 0029073706
- Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-a after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen
- (1995) Eur. J. Cancer , vol.31 A , pp. 876-881
- Atzpodien, J.¹ Hänninen, E.² Kirchner, H.³

19
- 0031424974
- Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma
- (1997) Cancer J. Sci. Am. , vol.3 , Issue.Suppl 1
- Thompson, J.¹ Gold, P.² Markowitz, D.³ Byrd, D.⁴ Lindgren, C.⁵ Fefer, A.⁶

20
- 0035397975
- Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials
- (2001) J. Clin. Oncol. , vol.19 , pp. 3194-3202
- Flaherty, L.¹ Atkins, M.² Sosman, J.³

21
- 0003217919
- Phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide (CVT), interleukin-2 (IL-2) and interferon-a-2b (IFN) in patients with metastatic melanoma
- (2001) Proc. Am. Soc. Clin. Oncol. , vol.21
- Atkins, M.¹ Gollob, J.² Mier, J.³

22
- 0003227197
- Response and survival in melanoma patients treated with biochemotherapy
- (2001) Proc. Am. Soc. Clin. Oncol. , vol.20
- Chapman, P.¹ Williams, L.² Wolchok, J.³

23
- 0031936639
- Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma
- (1998) Br. J. Cancer , vol.77 , pp. 1280-1286
- Johnston, S.¹ Constenla, D.² Moore, J.³

24
- 0031718717
- Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients
- (1998) J. Clin. Oncol. , vol.16 , pp. 2921-2929
- Keilholz, U.¹ Conradt, C.² Legha, S.³

25
- 0000645524
- Efficacy of interleukin-2 in the treatment of metastatic melanoma-systematic review and meta-analysis
- (1998) Sel. Cancer Ther. , vol.1 , pp. 168-173
- Allen, I.¹ Kupelnick, B.² Kumashiro, M.³

26
- 0342894822
- Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group
- (1997) J. Clin. Oncol. , vol.15 , pp. 2579-2588
- Keilholz, U.¹ Goey, S.² Punt, C.³

27
- 0344791670
- Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-a-2a in patients with metastatic melanoma
- (1999) Cancer , vol.85 , pp. 1060-1066
- Dorval, T.¹ Negrier, S.² Chevreau, C.³

28
- 0032976897
- Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
- (1999) J. Clin. Oncol. , vol.17 , pp. 968-975
- Rosenberg, S.¹ Yang, J.² Schwartsentruber, D.³

29
- 0000557793
- Phase III randomized trial of cisplatin, vinblastine and dacarbazine (CVD) plus interleukin-2 (IL-2) and interferon-alpha-2b (INF) versus CVD in patients (pts) with metastatic melanoma
- (2000) Proc. Am. Soc. Clin. Oncol. , vol.19
- Eton, O.¹ Legha, S.² Bedikian, A.³

30
- 4243944115
- Chemotherapy (CT) vs. biochemotherapy (BioCT): phase III trial in outpatients with advanced melanoma
- (2001) Proc. Am. Soc. Clin. Oncol. , vol.21
- Ridolfi, R.¹ Romanini, A.² Labianca, R.³ Lo Re, G.⁴ Freschi, A.⁵ Ravaioli, A.⁶

31
- 0034813919
- Practical guidelines for the management of biochemotherapy-related toxicity in melanoma
- (2001) Clin. Cancer Res. , vol.7 , pp. 2611-2619
- Buzaid, A.C.¹ Atkins, M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.